HIA
EW icon

HFM Investment Advisors’s Edwards Lifesciences EW Stock Holding History

HFM Investment Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04K Buy
13
+2
+18% +$165 ﹤0.01% 398
2025
Q4 		$938 Sell
11
-1
-8% -$82 ﹤0.01% 478
2025
Q3 		$933 Hold
12
– – ﹤0.01% 407
2025
Q2 		$939 Buy
12
+6
+100% +$447 ﹤0.01% 383
2025
Q1 		$435 Buy
+6
New +$429 ﹤0.01% 335

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HFM Investment Advisors's EW Position: Q1 2026 in Review

HFM Investment Advisors increased its Edwards Lifesciences (EW) stake by 18% in Q1 2026, buying an estimated $165 and bringing the position to 13 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #398.

HFM Investment Advisors first reported a position in EW in Q1 2025 and has held it in 5 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • HFM Investment Advisors held 13 shares of Edwards Lifesciences worth $1.04K as of Q1 2026.
  • HFM Investment Advisors bought 2 Edwards Lifesciences shares in Q1 2026, an estimated $165.
  • Edwards Lifesciences made up ﹤0.01% of HFM Investment Advisors's portfolio in Q1 2026, its #398 holding.
  • HFM Investment Advisors first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 5 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on HFM Investment Advisors's 13F filing for Q1 2026, filed 1 May 2026.